These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 16177881)
1. Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O Virchows Arch; 2006 Feb; 448(2):127-34. PubMed ID: 16177881 [TBL] [Abstract][Full Text] [Related]
2. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O Pathol Int; 2006 Dec; 56(12):717-23. PubMed ID: 17096728 [TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063 [TBL] [Abstract][Full Text] [Related]
4. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma. Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Netto GC; Bleil CB; Hilbig A; Coutinho LM Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830 [TBL] [Abstract][Full Text] [Related]
6. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008 [TBL] [Abstract][Full Text] [Related]
7. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study. Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360 [TBL] [Abstract][Full Text] [Related]
10. Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers. di Tomaso E; Capen D; Haskell A; Hart J; Logie JJ; Jain RK; McDonald DM; Jones R; Munn LL Cancer Res; 2005 Jul; 65(13):5740-9. PubMed ID: 15994949 [TBL] [Abstract][Full Text] [Related]
11. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073 [TBL] [Abstract][Full Text] [Related]
12. Specific expression of endoglin (CD105) in endothelial cells of intratumoral blood and lymphatic vessels in pancreatic cancer. Yoshitomi H; Kobayashi S; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Miyazaki M Pancreas; 2008 Oct; 37(3):275-81. PubMed ID: 18815549 [TBL] [Abstract][Full Text] [Related]
13. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V; Cerasoli S; Vitarelli E; Tuccari G Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Takahashi N; Haba A; Matsuno F; Seon BK Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features. Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma. Raica M; Cimpean AM; Anghel A Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316 [TBL] [Abstract][Full Text] [Related]
17. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers]. Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873 [TBL] [Abstract][Full Text] [Related]
18. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Saad RS; Liu YL; Nathan G; Celebrezze J; Medich D; Silverman JF Mod Pathol; 2004 Feb; 17(2):197-203. PubMed ID: 14657950 [TBL] [Abstract][Full Text] [Related]
19. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival. Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379 [TBL] [Abstract][Full Text] [Related]
20. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium? Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]